MorphoSys AG (Frankfurt: MOR; Prime Standard Segment) announced today the departure of Dr. Thomas von Rüden, Chief Scientific Officer, from the Company. The departure will take place with immediate effect. Until a successor is appointed, the Company will continue to be managed by the other two Board members, Dr. Simon Moroney, Chief Executive Officer, and Dave Lemus, Chief Financial Officer. Dr. Moroney will add Research and Development to his responsibilities, while Dave Lemus will add Technical Operations to his responsibilities.
Simultaneously, MorphoSys announced two promotions within the Company at the Vice President and Director level. Dr. Marlies Sproll, presently Vice President of Research and Development, is promoted to Senior Vice President in the same capacity. Dr. Barbara Krebs, presently Director of Business Development, is promoted to Senior Director.